Navigation Links
New Details Presented at the World Parkinson Congress on Neurologix's Successful Phase 2 Trial of Gene Therapy for Parkinson's Disease
Date:10/1/2010

Style" type="disc">
  • The Company is still in the development stage and has not generated any revenues. From inception through June 30, 2010, it incurred net losses and negative cash flows from operating activities of approximately $55.7 million and $41.6 million, respectively. Management believes that the Company will continue to incur net losses and cash flow deficiencies from operating activities for the foreseeable future. Because it may take years to develop, test and obtain regulatory approval for a gene-based therapy product before it can be sold, the Company likely will continue to incur significant losses for the foreseeable future. Accordingly, it may never be profitable and, if it does become profitable, it may be unable to sustain profitability.
  • At June 30, 2010, the Company had cash and cash equivalents of approximately $4.5 million. Based on its cash flow projections, the Company will need additional financing to carry out its planned business activity and to complete its plan of operations through December 31, 2010. At the Company's present level of activities, the Company's cash and cash equivalents are believed, at this time, to be sufficient to fund its operations only into the fourth quarter of 2010. Accordingly, there is substantial doubt as to the Company's ability to continue as a going concern. The Company is currently seeking to raise funds, through public or private equity offerings, debt financings or corporate collaboration and licensing arrangements, sufficient to finance its ongoing operations. The Company does not know whether additional financing will be available when needed, or if available, will be on acceptable or favorable terms to it or its stockholders.
  • The Company will need to conduct future clinical trials for treatment of Parkinson's disease using the Company's NLX technology. If the trials prove unsuccessful, future operations and the potential for profitability will be materially adversel
    '/>"/>

  • SOURCE Neurologix, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. PulmoBioTech Announces Details of Its Regulatory Approval Experiments
    2. Pulmo BioTech Announces Details of the Methodology for its Phase I Human Trials
    3. Newly Published Article Details How PGS Techniques Directly Effect Successful Pregnancy Outcomes
    4. Kendle Announces Details Regarding Third Quarter 2009 Earnings Conference Call and Webcast
    5. Young Innovations, Inc. Provides Third Quarter Conference Call Details
    6. Cord Blood America Details Las Vegas Laboratory Progress in Analyst Interview
    7. Young Innovations, Inc. Provides 4th Quarter Conference Call Details
    8. Kendle Announces Details Regarding Second Quarter 2010 Earnings Conference Call and Webcast
    9. Young Innovations, Inc. Provides 2nd Quarter Conference Call Details
    10. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
    11. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/10/2014)... Virginia , 11. Juli 2014 ... von Kameras für die molekulare Bildgebung, ... hat heute die CE-Zulassung für sein ... CE-Zeichen kann Dilon das Produkt jetzt ... auf den Großteil der europäischen Länder ...
    (Date:7/10/2014)... , July 10, 2014  RESMED INC. (NYSE: ... fourth quarter and fiscal year ended June 30, 2014 results ... Exchange market close. A press release with ResMed,s results will ... company will host a webcast to discuss operating results and ... begin at 1:30 p.m. US Pacific Time and the live ...
    (Date:7/10/2014)... 10, 2014   Ventana Medical Systems, Inc.  (Ventana), ... has entered into an agreement with Merck KGaA, Darmstadt, ... Serono in the United States ... Merck KGaA,s biopharmaceutical division on the development and commercialization ... using Ventana,s proprietary diagnostic assays. In alignment with Merck ...
    Breaking Medicine Technology:Dilon erhält CE-Zulassung für sein Navigator-Gamma-Sondensystem 2ResMed To Announce Fourth Quarter And Fiscal Year-End 2014 Results 2Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 2Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 3
    ... Fenwick & West, a leading technology and life sciences ... joined the firm as a partner in its Life Sciences ... clients as a strategic counselor on a broad range of ... and secretary at AVI BioPharma, Ms. Toshav is based in ...
    ... 14, 2012 Medical device recalls increased more than ... more than five times as many units than the ... released today. Products impacted by the increase ... Consumer product recalls also increased in the first quarter ...
    Cached Medicine Technology:Effie Toshav Joins Fenwick - Broadens Life Sciences Service Platform 2Medical Device Recalls Soar During First Quarter, ExpertRECALL Index Shows 2Medical Device Recalls Soar During First Quarter, ExpertRECALL Index Shows 3
    (Date:7/11/2014)... News) -- In people with sex addiction, pornography affects ... seen in drug addicts as they consume drugs, a ... brain activity between patients who have compulsive sexual behavior ... addicts," study author Dr. Valerie Voon, of the University ... release. Voon,s research involved 19 men with sex ...
    (Date:7/11/2014)... Ticket Down is a reliable source for cheap Luke ... to the summer concert schedule, it just isn’t complete without a ... the biggest names in country music and one of the biggest ... “That’s My Kind of Night” tour featuring Lee Brice and Cole ... the rest of the summer and into the fall includes the ...
    (Date:7/11/2014)... According to a new market research report “Internet ... (ZigBee, Z-Wave, Bluetooth, Wi-Fi, NFC, RFID), Application Vertical (Building ... & Geography - Global Trends & Forecasts to 2014 ... was worth $1029.5 Billion in 2013, and is expected ... CAGR of 4.08% from 2014 to 2020. , ...
    (Date:7/11/2014)... July 11, 2014 Presently, disposable medical ... healthcare equipment and supplies segment. During the past two ... steady growth (on an average 12.5% per year), primarily ... settings. Currently, the US is the largest market for ... share of 40%. The second position is held by ...
    (Date:7/11/2014)... and overweight firefighters are not receiving weight management ... new research from The University of Texas Health ... state that health care professionals (HCPs) should advise ... weight. Firefighters have high rates of obesity, and ... deaths in firefighters. This study assessed the association ...
    Breaking Medicine News(10 mins):Health News:Brains of Sex Addicts May Be Wired Like Those of Drug Addicts, Study Finds 2Health News:Luke Bryan Ticket Prices Slashed at Concord Pavilion 2Health News:Luke Bryan Ticket Prices Slashed at Concord Pavilion 3Health News:Internet of Things Technology & Application Market Worth $1423.09 Billion by 2020 – New Report by MarketsandMarkets 2Health News:Internet of Things Technology & Application Market Worth $1423.09 Billion by 2020 – New Report by MarketsandMarkets 3Health News:Internet of Things Technology & Application Market Worth $1423.09 Billion by 2020 – New Report by MarketsandMarkets 4Health News:Global Disposable Medical Supplies Market to See Robust Growth Through Next Decade, According to New TriMark Report Available at MarketPublishers.com 2Health News:Global Disposable Medical Supplies Market to See Robust Growth Through Next Decade, According to New TriMark Report Available at MarketPublishers.com 3
    ... and laymen gathered at temples throughout Thailand Thursday to ... admitted earlier in the day to a Bangkok hospital ... of Buddhist temples nationwide staged hour-long prayers for the ... night. ,More than 1,000 well-wishers had gathered ...
    ... Common cold and running nose in children does not ... effect, antibiotics should be administered// only if the child's ... effects. ,Antibiotics consumption at every small pretext, ... super bugs that are able to defeat even the ...
    ... nurse subsidy should be offered to all general practices in ... ,"Family doctors want to look after their patients as ... the best possible health care at a time when Australia's ... into general practice makes sense to them and it should ...
    ... has claimed the lives of at least 234 cattle and ... is caused by a spore-forming bacterium, shed by an infected ... high temperatures. It is often a fatal disease in cattle. ... ,The provincial government has reported that the latest outbreak ...
    ... said it has got the approval of US Food and ... (ANDA) for Meloxicam tablets used in the treatment of osteoarthritis ... Meloxicam tablets of strengths of 7.5 mg and 15 mg ... approval of our Meloxicam ANDA further reinforces Lupin's ability on ...
    ... Australian children are to be weighed, measured and interviewed ... tackle //the growing menace of childhood obesity. The Australian ... children aged between 7 and 15, are either overweight ... incidence of heart disease and diabetes. Federal Health Minister ...
    Cached Medicine News:Health News:Call For Better Funding Of Doctor-Nurse Teams 2
    ... balloon. ,The first outside-the-balloon, dual-wire dilatation catheter. ... represents an innovative new approach to dilatation. ... the two wires to create expansion planes ... challenging lesions. ,The FX miniRAIL RX PTCA ...
    ... intravascular catheters provide a simple, efficient ... pressures in the heart or cardiovascular ... are ideal for high fidelity pressure ... from 2 to 7 French and ...
    ... Millar Mikro-Tip pressure intravascular catheters ... accurate method of measuring pressures in ... reusable, thromboresistant Mikro-Tip catheters are ideal ... catheters range in size from 2 ...
    ... pressure sensor catheters incorporate a ... injection/guide wire, or high-speed injection/guide ... high-speed injection has two laterally ... an open-end pigtail extension for ...
    Medicine Products: